📇 Rhumatologue · PARIS CEDEX 18 · (75) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
5 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
35 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
Expérience confirmée
31 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
31ans d'exercice (thèse 1995)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
10
10 articles ont été cités au moins 10fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
1 919
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
27
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
10
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Assistance Publique – Hôpitaux de Paris · Hôpital Bichat-Claude-Bernard
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Serological diagnosis of chronic skin granulomas caused by wild-type or vaccine-derived rubella virus in patients with inherited HLA class I deficiency
2025ArticleJournal of Human Immunity
Detection of alpha-HPV types in cutaneous squamous cell carcinoma associated with markers of carcinogenesis: a retrospective study
2025ArticleClinical and Experimental Dermatology
Diagnosing and Managing Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017–2023
2025ArticleJournal of Investigative Dermatology
PARKIN Inactivation Links Parkinson's Disease to Melanoma
2025ArticleJNCI: Journal of the National Cancer Institute
Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.
2024ArticleJournal of The American Academy of Dermatology
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2024ArticleGenome Medicine
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms
2024ArticleJAMA Dermatology
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2023ArticleGenome Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE BICHAT C BERNARD
46 R HENRI HUCHARD, 75877 PARIS CEDEX 18
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
International journal of cardiology · 2019
JAMA dermatology · 2024
ImportanceDrug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but potentially fatal drug hypersensitivity reaction. To our knowledge, there is no international consensus on its severity assessment and treatment.ObjectiveTo reach an international, Delphi-based multinational expert consensus on the diagnostic workup, severity assessment, and treatment of patients with DRESS.Design, Setting, and ParticipantsThe Delphi method was used to assess 100 statements related to baseline workup, evaluation of severity, acute phase, and postacute management of DRESS. Fifty-seven international experts in DRESS were invited, and 54 participated in the survey, which took place from July to September 2022.Main Outcomes/MeasuresThe degree of agreement was calculated with the RAND-UCLA Appropriateness Method. Consensus was defined as a statement with a median appropriateness value of 7 or higher (appropriate) and a disagreement index of lower than 1.ResultsIn the first Delphi round, consensus was reached on 82 statements. Thirteen statements were revised and assessed in a second round. A consensus was reached for 93 statements overall. The experts agreed on a set of basic diagnostic workup procedures as well as severity- and organ-specific further investigations. They reached a consensus on severity assessment (mild, moderate, and severe) based on the extent of liver, kidney, and blood involvement and the damage of other organs. The panel agreed on the main lines of DRESS management according to these severity grades. General recommendations were generated on the postacute phase follow-up of patients with DRESS and the allergological workup.Conclusions and RelevanceThis Delphi exercise represents, to our knowledge, the first international expert consensus on diagnostic workup, severity assessment, and management of DRESS. This should support clinicians in the diagnosis and management of DRESS and constitute the basis for development of future guidelines.
Mayo Clinic proceedings · 2021
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
European journal of dermatology : EJD · 2023 · Multicenter Study
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, et al.
Clinical and experimental dermatology · 2023 · Journal Article
Lutz W, Bertin C, Merlant M, Mailhe M, et al.
The New England journal of medicine · 2022 · Letter
Descamps V
Lancet (London, England) · 2022 · Letter
Descamps V
Joint bone spine · 2022 · Letter
Richette P, Allez M, Descamps V, Perray L, et al.
Respiratory medicine and research · 2021 · Letter
Descamps V, Deschamps L, El Khalifa J, Groh M, et al.
Mayo Clinic proceedings · 2021 · Journal Article
Fournier M, Faille D, Dossier A, Mageau A, et al.
Journal of the American Academy of Dermatology · 2020 · Letter
Salle R, Chasset F, Kottler D, Picard-Dahan C, et al.
International journal of dermatology · 2020 · Case Reports
Kluger N, Descamps V, Lappalainen K, Roivainen R
Annales de dermatologie et de venereologie · 2019 · Case Reports
Merlant M, Fite C, Kottler D, Maisonobe L, et al.
British journal of clinical pharmacology · 2019 · Journal Article
Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, et al.
International journal of cardiology · 2019 · Comparative Study
Ballul T, Borie R, Crestani B, Daugas E, et al.
Medicine · 2019 · Journal Article
Bertin C, Abbas R, Andrieu V, Michard F, et al.
NPJ genomic medicine · 2018 · Journal Article
Prusty BK, Gulve N, Chowdhury SR, Schuster M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Bertin C, Beaumont AL, Merlant M, Mailhe M, et al.
Clinical case reports · 2021 · Case Reports
Descamps V, Gautheret-Dejean A, Pelletier AL, Bonnafous P, et al.
Journal of cutaneous pathology · 2018 · Case Reports
Nassereddine H, Fite C, Kottler D, Descamps V, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Journal Article
Gaillet A, Layese R, Oubaya N, Sbidian E, et al.
JAMA dermatology · 2021 · Journal Article
Roux C, Sbidian E, Bouaziz JD, Kottler D, et al.
PloS one · 2020 · Journal Article
Borie R, Savale L, Dossier A, Ghosn J, et al.
Scientific reports · 2022 · Journal Article
Beydon M, Nicaise-Roland P, Mageau A, Farkh C, et al.
Journal of the American Academy of Dermatology · 2020 · Comparative Study
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, et al.
International journal of dermatology · 2020 · Letter
The oncologist · 2025 · Journal Article
de Givry AC, Manchon P, Veyri M, Delyon J, et al.
Acta dermato-venereologica · 2020 · Journal Article
Phan C, Beneton N, Delaunay J, Reguiai Z, et al.
Clinical case reports · 2019 · Case Reports
Al Dhafiri M, Sicre de Fontbrune F, Marinho E, Deschamps L, et al.
Journal of the American Academy of Dermatology · 2024 · Multicenter Study
Ingen-Housz-Oro S, Guichard E, Milpied B, Bensaid B, et al.
BMJ open · 2019 · Clinical Trial Protocol
Javaud N, Soria A, Maignan M, Martin L, et al.
Rheumatology (Oxford, England) · 2021 · Journal Article
Weill A, Delyon J, Descamps V, Deschamps L, et al.
Acta dermato-venereologica · 2020 · Journal Article
Phan C, Beneton N, Delaunay J, Reguiai Z, et al.
JAMA dermatology · 2024 · Journal Article
Brüggen MC, Walsh S, Ameri MM, Anasiewicz N, et al.
Advances in therapy · 2022 · Journal Article
Richard MA, Aubin F, Beneton N, Bouloc A, et al.
Acta dermato-venereologica · 2023 · Review
Skayem C, Askour M, Gary C, Hemery F, et al.
Journal of cutaneous pathology · 2018 · Case Reports
Nassereddine H, Fite C, Kottler D, Descamps V, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2024 · Letter
Sambourg J, Maravic M, Descamps V
International journal of dermatology · 2020 · Letter
Mazgaj M, Picard-Dahan C, Deschamps L, Marinho E, et al.
Dermatologic therapy · 2022 · Letter
Demouche S, Juge PA, Charles P, Descamps V, et al.
Acta dermato-venereologica · 2020 · Journal Article
Phan C, Beneton N, Delaunay J, Reguiai Z, et al.
JAMA dermatology · 2019 · Case Reports
Brunet-Possenti F, Charpentier C, Bouhnik Y, Deschamps L, et al.
Early Identification and Management of Patients with Rash on Apalutamide
<br> The above infographic represents the opinions of the <strong>authors</strong>. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full tex
Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy
<b>Article full text</b> <br> The full text of this article can be found here<b>. </b>https://link.springer.com/article/10.1007/s13555-017-0196-z <br> <b>Provide enhanced content for this article</b> <br> If you are an a
Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy
<b>Article full text</b> <br> The full text of this article can be found here<b>. </b>https://link.springer.com/article/10.1007/s13555-017-0196-z <br> <b>Provide enhanced content for this article</b> <br> If you are an a
Early Identification and Management of Patients with Rash on Apalutamide
<br> The above infographic represents the opinions of the <strong>authors</strong>. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full tex
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Mazgaj M, Picard-Dahan C, Deschamps L, Marinho E, et al.